Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024
Projections for the US 2023-24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022-23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.
Authors
- Anass Bouchnita (ORCID: https://orcid.org/0000-0002-2729-6484)
- Kaiming Bi (ORCID: https://orcid.org/0000-0001-6234-6232)
- Shraddha Ramdas Bandekar (ORCID: https://orcid.org/0000-0001-5063-2290)
- Spencer J. Fox (ORCID: https://orcid.org/0000-0003-1969-3778)
- Lauren Ancel Meyers (ORCID: https://orcid.org/0000-0002-5828-8874)
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2025-02-21
- DOI
- https://doi.org/10.3201/eid3103.240594
- Citations
- 6
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 8.38